Back to top
For the year ended 31 December 2025
(Expressed in millions of Renminbi, unless otherwise stated)
NoteShare capital
Note
47(a)
Capital reserve
Note
47(b)(i)
Hedging reserve
Note
47(b)(ii)
Investment related reserves
Note
47(b)(iii)
General reserve
Note
47(b)(iv)
Exchange reserve
Note
47(b)(v)
Retained earningsTotalNon-controlling interests Total equity
Balance at 1 January 2025 307,576(37,442)2,441(3,271)64,8279,176414,180757,487665,5271,423,014
Profit for the year 58,73058,73057,083115,813
Other comprehensive loss for the year17 (81)(9,722) (2,280) (12,083)(6,161)(18,244)
Total comprehensive income for the year (81)(9,722) (2,280)58,73046,64750,92297,569
Transactions with non-controlling interests 418 418(777)(359)
Appropriation to general reserve 6,828 (6,828)
Dividends paid to ordinary shareholders of the Company15 (16,291)(16,291) (16,291)
Dividends paid to non-controlling interests (21,707)(21,707)
Conversion of a subsidiary’s convertible corporate bonds (5,892) (5,892)12,8116,919
Other equity instruments issued by subsidiaries53 (c) (3) (3)7,4887,485
Disposal of equity investments at fair value through other comprehensive income 987 (987)
Share of other comprehensive income of associates and joint ventures that will not be reclassified subsequently to profit or loss 30 (30)
Others (17) (17)4831
Other changes in equity (5,494) 1,0176,828 (24,136)(21,785)(2,137)(23,922)
Balance at 31 December 2025 307,576(42,936)2,360(11,976)71,6556,896448,774782,349714,3121,496,661
NoteShare capital
Note
47(a)
Capital reserve
Note
47(b)(i)
Hedging reserve
Note
47(b)(ii)
Investment related reserves
Note
47(b)(iii)
General reserve
Note
47(b)(iv)
Exchange reserve
Note
47(b)(v)
Retained earningsTotalNon-controlling interests Total equity
Balance at 1 January 2024 307,576(42,395)2,539(8,232)59,5567,842376,292703,178633,6041,336,782
Profit for the year 58,20258,20249,553107,755
Other comprehensive (loss)/income for the year 17 (98)5,190 1,334 6,4263,92210,348
Total comprehensive income for the year (98)5,190 1,33458,20264,62853,475118,103
Transactions with non-controlling interests 1,274 1,274(289)985
Appropriation to general reserve 5,271 (5,271)
Dividends paid to ordinary shareholders of the Company 15 (15,272)(15,272) (15,272)
Dividends paid to non-controlling interests (27,522)(27,522)
Conversion of a subsidiary’s convertible corporate bonds 3,694 3,6942,5186,212
Other equity instruments issued by subsidiaries 53 (c) 44,00044,000
Other equity instruments redeemed by subsidiaries 53 (c) (39,993)(39,993)
Disposal of equity investments at fair value through other comprehensive income 181 (181)
Share of other comprehensive income of associates and joint ventures that will not be reclassified subsequently to profit or loss (410) 410
Others (15) (15)(266)(281)
Other changes in equity 4,953 (229)5,271 (20,314)(10,319)(21,552)(31,871)
Balance at 31 December 2024 307,576(37,442)2,441(3,271)64,8279,176414,180757,487665,5271,423,014

The notes form part of these consolidated financial statements.